Copy Number Variations on Chromosome 2: Impact on Human Phenotype, a Cross-sectional Study

Overview

Journal Porto Biomed J

Publisher Wolters Kluwer

Specialty Biomedical Engineering

Date 2023 May 22

PMID 37213247

Authors

Beatriz Sousa

Ana Grangeia

Joel Pinto

Helena Santos

Sofia Doria

Affiliations

Soon will be listed here.

Abstract

Background: Copy number variations (CNVs) on chromosome 2 are associated with a variety of human diseases particularly neurodevelopmental disorders. Array comparative genomic hybridization (aCGH) constitutes an added value for the diagnosis of neurodevelopmental or neuropsychiatric diseases. This study aims to establish a genotype-phenotype correlation, reporting CNVs on the chromosome 2, contributing for a better characterization of the molecular significance of rare CNVs in this chromosome.

Methods: To accomplish this, a cross-sectional study was performed using genetic information included in a database of the Department of Genetics of the Faculty of Medicine and clinical data from Hospital database. CNVs were classified as pathogenic, benign, variants of unknown significance, and likely pathogenic or likely benign, in accordance with the ACMG Standards and Guidelines.

Results: A total of 2897 patients were studied using aCGH, 32 with CNVs on chromosome 2, 24 classified as likely pathogenic, and 8 as pathogenic. Genomic intervals with a higher incidence were one 2p25.3 and 2q13 regions.

Conclusions: This study will help to establish new genotype-phenotype correlations, allowing update of databases and literature and the improvement of diagnosis and genetic counseling which could be an added value for prenatal genetic counseling.

Citing Articles

Breaking new ground: Exploring chromosomal rearrangements in 1p36 microdeletion.

Al Eissa M, Alotibi R, Alqahtani A, Aldriwesh M, Alismail H, Asiri N Int J Health Sci (Qassim). 2024; 18(4):70-77.

PMID: 38974650 PMC: 11226937.

References

Zarate Y, Bosanko K, Caffrey A, Bernstein J, Martin D, Williams M . Mutation update for the SATB2 gene. Hum Mutat. 2019; 40(8):1013-1029. PMC: 11431158. DOI: 10.1002/humu.23771. View

Ching M, Shen Y, Tan W, Jeste S, Morrow E, Chen X . Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B(4):937-47. PMC: 3001124. DOI: 10.1002/ajmg.b.31063. View

Hladilkova E, Baroy T, Fannemel M, Vallova V, Misceo D, Bryn V . A recurrent deletion on chromosome 2q13 is associated with developmental delay and mild facial dysmorphisms. Mol Cytogenet. 2015; 8:57. PMC: 4521466. DOI: 10.1186/s13039-015-0157-0. View

Shashi V, Pena L, Kim K, Burton B, Hempel M, Schoch K . De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype. Am J Hum Genet. 2016; 99(4):991-999. PMC: 5065681. DOI: 10.1016/j.ajhg.2016.08.017. View

Holt R, Sykes N, Conceicao I, Cazier J, Anney R, Oliveira G . CNVs leading to fusion transcripts in individuals with autism spectrum disorder. Eur J Hum Genet. 2012; 20(11):1141-7. PMC: 3476715. DOI: 10.1038/ejhg.2012.73. View

Bonnet C, Ali Khan A, Bresso E, Vigouroux C, Beri M, Lejczak S . Extended spectrum of MBD5 mutations in neurodevelopmental disorders. Eur J Hum Genet. 2013; 21(12):1457-61. PMC: 3831065. DOI: 10.1038/ejhg.2013.22. View

Jun K, Ullmann R, Khan S, Layman L, Kim H . Interstitial microduplication at 2p11.2 in a patient with syndromic intellectual disability: 30-year follow-up. Mol Cytogenet. 2014; 7:52. PMC: 4188067. DOI: 10.1186/1755-8166-7-52. View

Borna N, Kishita Y, Kohda M, Lim S, Shimura M, Wu Y . Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome. Neurogenetics. 2019; 20(1):9-25. DOI: 10.1007/s10048-018-0561-9. View

Abe K, Chisaka O, van Roy F, Takeichi M . Stability of dendritic spines and synaptic contacts is controlled by alpha N-catenin. Nat Neurosci. 2004; 7(4):357-63. DOI: 10.1038/nn1212. View

10.

Talkowski M, Mullegama S, Rosenfeld J, van Bon B, Shen Y, Repnikova E . Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet. 2011; 89(4):551-63. PMC: 3188839. DOI: 10.1016/j.ajhg.2011.09.011. View

11.

Reissner C, Klose M, Fairless R, Missler M . Mutational analysis of the neurexin/neuroligin complex reveals essential and regulatory components. Proc Natl Acad Sci U S A. 2008; 105(39):15124-9. PMC: 2551626. DOI: 10.1073/pnas.0801639105. View

12.

Costain G, Lionel A, Fu F, Stavropoulos D, Gazzellone M, Marshall C . Adult neuropsychiatric expression and familial segregation of 2q13 duplications. Am J Med Genet B Neuropsychiatr Genet. 2014; 165B(4):337-44. PMC: 4464821. DOI: 10.1002/ajmg.b.32236. View

13.

Katoh M, Katoh M . Identification and characterization of ASXL2 gene in silico. Int J Oncol. 2003; 23(3):845-50. View

14.

Riley K, Catalano L, Bernat J, Adams S, Martin D, Lalani S . Recurrent deletions and duplications of chromosome 2q11.2 and 2q13 are associated with variable outcomes. Am J Med Genet A. 2015; 167A(11):2664-73. DOI: 10.1002/ajmg.a.37269. View

15.

Williams S, Aldred M, Der Kaloustian V, Halal F, Gowans G, McLeod D . Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am J Hum Genet. 2010; 87(2):219-28. PMC: 2917703. DOI: 10.1016/j.ajhg.2010.07.011. View

16.

Redon R, Ishikawa S, Fitch K, Feuk L, Perry G, Andrews T . Global variation in copy number in the human genome. Nature. 2006; 444(7118):444-54. PMC: 2669898. DOI: 10.1038/nature05329. View

17.

Alfieri P, Scibelli F, Sinibaldi L, Valeri G, Caciolo C, Novello R . Further insight into the neurobehavioral pattern of children carrying the 2p16.3 heterozygous deletion involving NRXN1: Report of five new cases. Genes Brain Behav. 2020; 19(7):e12687. DOI: 10.1111/gbb.12687. View

18.

Ijdo J, Baldini A, Ward D, Reeders S, Wells R . Origin of human chromosome 2: an ancestral telomere-telomere fusion. Proc Natl Acad Sci U S A. 1991; 88(20):9051-5. PMC: 52649. DOI: 10.1073/pnas.88.20.9051. View

19.

Tzschach A, Graul-Neumann L, Konrat K, Richter R, Ebert G, Ullmann R . Interstitial deletion 2p11.2-p12: report of a patient with mental retardation and review of the literature. Am J Med Genet A. 2009; 149A(2):242-5. DOI: 10.1002/ajmg.a.32637. View

20.

Usui D, Shimada S, Shimojima K, Sugawara M, Kawasaki H, Shigematu H . Interstitial duplication of 2q32.1-q33.3 in a patient with epilepsy, developmental delay, and autistic behavior. Am J Med Genet A. 2013; 161A(5):1078-84. DOI: 10.1002/ajmg.a.35679. View